No registrations found.
Source
Health condition
RA and SpA
Sponsors and support
Intervention
No registrations found.
Outcome measures
Primary outcome
To identify novel biomarker reflexting cellular and molecular processes of the pathophysiology of chronic inflammatory arthritis, inclusie RA and SpA and to validate these biomarkers.
Secondary outcome
Generate a biobank with biological samples and clinical data in RA and SpA for the purpose of the development and validation of novel biomarkers.
Background summary
Country of recruitment: The Netherlands.
Study objective
The goal of this study is to identify and validate recently discovered and novel biomarkers of pathophysiology, diagnosis, classification, disease activity, prognosis, treatment susceptibility, and treatment efficacy in chronic inflammatory arthritic diseases, including RA and SpA.
Study design
One measurement.
Intervention
N/A
P.O. Box 22660
P.P. Tak
Amsterdam 1100 DD
The Netherlands
+31 (0)20 5662171
p.p.tak@amc.nl
P.O. Box 22660
P.P. Tak
Amsterdam 1100 DD
The Netherlands
+31 (0)20 5662171
p.p.tak@amc.nl
Inclusion criteria
All patients 18 years or older with a diagnosis of chronic inflammatory arthritis e.g. rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, osteoarthritis, crystal arthropathy and undifferentiated arthritis, can be invited to participate in this study
Exclusion criteria
Not able to give consent.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL2303 |
NTR-old | NTR2832 |
Other | MEC AMC : 10/239 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |